Little Evidence for Some ‘Off-Label' Uses of Atypical Antipsychotic Drugs
- Effective Health Care Program report shows little evidence to support off-label use of atypical antipsychotic medications (APMs) for substance abuse, eating disorders, or insomnia.
- Evidence does support use of some atypical APMs for dementia, anxiety, and obsessive-compulsive disorder.
Image: The first page of the executive summary for the off-label use of atypical antipsychotic medications report is shown.
Previous Slide Contents Next Slide